{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:16:33Z","timestamp":1782774993731,"version":"3.54.5"},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T00:00:00Z","timestamp":1452124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Ultrasound in Obstet &amp; Gyne"],"published-print":{"date-parts":[[2016,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the potential value of biophysical and biochemical markers at 30\u201334 weeks' gestation in the prediction of adverse perinatal outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a screening study in 8268 singleton pregnancies at 30\u201334 weeks' gestation. Estimated fetal weight (<jats:styled-content style=\"fixed-case\">EFW<\/jats:styled-content>), uterine artery (<jats:styled-content style=\"fixed-case\">UtA<\/jats:styled-content>) pulsatility index (<jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content>), umbilical artery (<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>) <jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content>, fetal middle cerebral artery (<jats:styled-content style=\"fixed-case\">MCA<\/jats:styled-content>) <jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content>, mean arterial pressure (<jats:styled-content style=\"fixed-case\">MAP<\/jats:styled-content>), serum placental growth factor (<jats:styled-content style=\"fixed-case\">PlGF<\/jats:styled-content>) and soluble fms\u2010like tyrosine kinase\u20101 (<jats:styled-content style=\"fixed-case\">sFlt<\/jats:styled-content>\u20101) were measured. The detection rate (<jats:styled-content style=\"fixed-case\">DR<\/jats:styled-content>) and false\u2010positive rate (<jats:styled-content style=\"fixed-case\">FPR<\/jats:styled-content>) of screening by each biomarker were estimated for stillbirth, pre\u2010eclampsia, delivery of small\u2010for\u2010gestational\u2010age (<jats:styled-content style=\"fixed-case\">SGA<\/jats:styled-content>) neonate, Cesarean section for fetal distress before or during labor, umbilical arterial cord blood <jats:styled-content style=\"fixed-case\">pH<\/jats:styled-content> \u22647.0 or umbilical venous cord blood <jats:styled-content style=\"fixed-case\">pH<\/jats:styled-content> \u22647.1, 5\u2010min Apgar score  &lt; 7 and admission to the neonatal unit (<jats:styled-content style=\"fixed-case\">NNU<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Multivariable regression analysis demonstrated that significant prediction of <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> was provided by <jats:styled-content style=\"fixed-case\">PlGF<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">sFlt<\/jats:styled-content>\u20101, <jats:styled-content style=\"fixed-case\">MAP<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MCA\u2010PI<\/jats:styled-content>, with a <jats:styled-content style=\"fixed-case\">DR<\/jats:styled-content> of 98% for <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> delivering &lt; 37 weeks' gestation and 56% for those delivering \u2265 37 weeks, at a 10% <jats:styled-content style=\"fixed-case\">FPR<\/jats:styled-content>. Prediction of <jats:styled-content style=\"fixed-case\">SGA<\/jats:styled-content> was provided by <jats:styled-content style=\"fixed-case\">EFW<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">PlGF<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">sFlt<\/jats:styled-content>\u20101, <jats:styled-content style=\"fixed-case\">UtA\u2010PI<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">UA\u2010PI<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MCA\u2010PI<\/jats:styled-content>, with a <jats:styled-content style=\"fixed-case\">DR<\/jats:styled-content> of 88% for <jats:styled-content style=\"fixed-case\">SGA<\/jats:styled-content> delivering &lt; 37 and 51% for those delivering \u2265 37 weeks' gestation, at a 10% <jats:styled-content style=\"fixed-case\">FPR<\/jats:styled-content>. Prediction of stillbirth was provided by <jats:styled-content style=\"fixed-case\">EFW<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">UtA\u2010PI<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MCA\u2010PI<\/jats:styled-content>, with <jats:styled-content style=\"fixed-case\">DR<\/jats:styled-content> of 30% at 10% <jats:styled-content style=\"fixed-case\">FPR<\/jats:styled-content>. Prediction of Cesarean section for fetal distress before labor was provided by <jats:styled-content style=\"fixed-case\">EFW<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">sFlt<\/jats:styled-content>\u20101, <jats:styled-content style=\"fixed-case\">UtA\u2010PI<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">UA\u2010PI<\/jats:styled-content>, with a <jats:styled-content style=\"fixed-case\">DR<\/jats:styled-content> of 90% at a 10% <jats:styled-content style=\"fixed-case\">FPR<\/jats:styled-content>. Prediction of fetal distress in labor was provided by <jats:styled-content style=\"fixed-case\">EFW<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">sFlt<\/jats:styled-content>\u20101, with a <jats:styled-content style=\"fixed-case\">DR<\/jats:styled-content> of 16% at a 10% <jats:styled-content style=\"fixed-case\">FPR<\/jats:styled-content>. There were no significant differences from the normal outcome group in any of the biomarkers for low cord blood <jats:styled-content style=\"fixed-case\">pH<\/jats:styled-content>, low Apgar score or <jats:styled-content style=\"fixed-case\">NNU<\/jats:styled-content> admission for cases other than those with <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> and\/or <jats:styled-content style=\"fixed-case\">SGA<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>At 30\u201334 weeks' gestation, biomarkers of impaired placentation and fetal hypoxemia provide good prediction of <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">SGA<\/jats:styled-content> and fetal distress before labor, but poor or no prediction of stillbirth and adverse events in labor or after birth. Copyright \u00a9 2015 ISUOG. Published by John Wiley &amp; Sons Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/uog.14928","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T23:18:30Z","timestamp":1434755910000},"page":"194-202","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Biophysical and biochemical markers at 30\u201334 weeks' gestation in the prediction of adverse perinatal outcome"],"prefix":"10.1002","volume":"47","author":[{"given":"N.","family":"Vali\u00f1o","sequence":"first","affiliation":[{"name":"Harris Birthright Research Centre for Fetal Medicine King's College Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giunta","sequence":"additional","affiliation":[{"name":"Harris Birthright Research Centre for Fetal Medicine King's College Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. M.","family":"Gallo","sequence":"additional","affiliation":[{"name":"Harris Birthright Research Centre for Fetal Medicine King's College Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Akolekar","sequence":"additional","affiliation":[{"name":"Harris Birthright Research Centre for Fetal Medicine King's College Hospital  London UK"},{"name":"Department of Fetal Medicine Medway Maritime Hospital  Gillingham Kent UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. H.","family":"Nicolaides","sequence":"additional","affiliation":[{"name":"Harris Birthright Research Centre for Fetal Medicine King's College Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,1,7]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000362518"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14863"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91333-4"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.294.6579.1051"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6655.1026"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1990.tb02573.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-199203000-00018"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.7863\/jum.2005.24.9.1223"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70283-8"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14647"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14822"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1975.tb00710.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0705.1994.04010034.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(00)00946-7"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.09.019"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1990.tb16250.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000338655"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/10641950109152635"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14789"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14824"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14783"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14811"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14817"}],"container-title":["Ultrasound in Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fuog.14928","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/uog.14928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T17:41:51Z","timestamp":1738345311000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1002\/uog.14928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,7]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.1002\/uog.14928"],"URL":"https:\/\/doi.org\/10.1002\/uog.14928","archive":["Portico"],"relation":{},"ISSN":["0960-7692","1469-0705"],"issn-type":[{"value":"0960-7692","type":"print"},{"value":"1469-0705","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,7]]},"assertion":[{"value":"2015-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-06-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-01-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}